Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioblastoma 2Central Nervous System Neoplasms 2Oligodendroglioma 1Gliosarcoma 1Cognition Disorders 1Brain Neoplasms 1Astrocytoma 1

Interventions

Radiotherapy 12Temozolomide 8Vincristine 6Procarbazine 5Lomustine 4Carboplatin 2Thiotepa 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Peripheral Blood Stem Cell Transplantation 1Methylphenidate 1Methotrexate 1Isotretinoin 1Fentanyl 1Etoposide 1Donepezil 1DNA Methylation 1Cyproheptadine 1Cyclophosphamide 1Cisplatin 1Chemotherapy, Adjuvant 1Carmustine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Oligodendroglioma × DNA Methylation × Clear all
NCT00626990 2023-09-11

CATNON

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Active not recruiting
751 enrolled 18 charts
CNS

Astrocytoma, Oligodendroglioma, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡